{"id":3019,"date":"2017-04-12T06:30:00","date_gmt":"2017-04-12T06:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/first-xps-sold-to-australia-and-to-the-netherlands\/"},"modified":"2017-04-12T06:30:00","modified_gmt":"2017-04-12T06:30:00","slug":"first-xps-sold-to-australia-and-to-the-netherlands","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-sold-to-australia-and-to-the-netherlands\/","title":{"rendered":"First XPS\u2122 sold to Australia and to the Netherlands"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>As was announced in the Report on Operations 2016, an XPS\u2122 contract has been entered into with Alfred Health, Melbourne, Australia. During the first quarter of 2017 an XPS has been sold to the Netherlands as well. Australia and the Netherlands are new countries with access to the XPS\u2122.<\/strong><\/div>\n<p><span>Delivery and installation of the Australian XPS\u2122 occurred in March 2017. Delivery of the XPS\u2122 to the Netherlands was made in March 2017 and the installation is estimated to take place in May 2017. \u00a0Alfred Health in Melbourne is a world leading clinic in the evaluation of DCD lungs (DCD = Donation after Circulatory Death) and has long experience of evaluating lungs using STEEN Solution\u2122. By using XPS\u2122 this process can now become more standardized and the evaluation of lungs can be simplified.<\/span><\/p>\n<p><span>According to the Company\u2019s business model, the pricing strategy for capital goods, that is the EVLP machines LS\u2122 and XPS\u2122, is so designed that sales of capital goods do not have a significant financial impact on the Company. According to the Company\u2019s pricing strategy, future sales of STEEN Solution\u2122 for use in the EVLP machines and accompanying single-use items are of financial significance for the Company. <\/span><\/p>\n<p><span>\u00a0\u201cWe are very pleased and proud that EVLP with XPS\u2122 and STEEN Solution\u2122 will be used to evaluate lungs for transplantation in Australia and the Netherlands. The clinic in Melbourne is a world leader in the evaluation of DCD lungs, an area where the Company sees great potential for growth in the future. The Company continues to see great interest from clinics worldwide in installing EVLP machines to facilitate the evaluation of lungs with a view to using more donated lungs,\u201d says Magnus Nilsson, CEO of XVIVO Perfusion.<\/span><\/p>\n<p><span>April 12, 2017<br \/><\/span>Gothenburg<br \/>Magnus Nilsson, CEO<br \/>XVIVO Perfusion AB (publ)<\/p>\n<div class=\"mfn-footer\">\n<p><span>For further information please contact:<\/span><\/p>\n<p><span>Christoffer Rosenblad, CFO, +1 720 616 2101, christoffer.rosenblad@xvivoperfusion.com<br \/>Magnus Nilsson, CEO, +46 31 788 2150, magnus.nilsson@xvivoperfusion.com<\/span><br \/><span>For further information on XVIVO Perfusion\u2019s business, please refer to the company\u2019s website, www.xvivoperfusion.com<\/span><\/p>\n<p><span>This information is information that Xvivo Perfusion AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 am CET on April 12, 2017.<\/span><\/p>\n<p><span>This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>As was announced in the Report on Operations 2016, an XPS\u2122 contract has been entered into with Alfred Health, Melbourne,&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-3019","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First XPS\u2122 sold to Australia and to the Netherlands - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-sold-to-australia-and-to-the-netherlands\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First XPS\u2122 sold to Australia and to the Netherlands - XVIVO\" \/>\n<meta property=\"og:description\" content=\"As was announced in the Report on Operations 2016, an XPS\u2122 contract has been entered into with Alfred Health, Melbourne,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-sold-to-australia-and-to-the-netherlands\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-xps-sold-to-australia-and-to-the-netherlands\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-xps-sold-to-australia-and-to-the-netherlands\\\/\",\"name\":\"First XPS\u2122 sold to Australia and to the Netherlands - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2017-04-12T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-xps-sold-to-australia-and-to-the-netherlands\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-xps-sold-to-australia-and-to-the-netherlands\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-xps-sold-to-australia-and-to-the-netherlands\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First XPS\u2122 sold to Australia and to the Netherlands\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First XPS\u2122 sold to Australia and to the Netherlands - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-sold-to-australia-and-to-the-netherlands\/","og_locale":"en_US","og_type":"article","og_title":"First XPS\u2122 sold to Australia and to the Netherlands - XVIVO","og_description":"As was announced in the Report on Operations 2016, an XPS\u2122 contract has been entered into with Alfred Health, Melbourne,...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-sold-to-australia-and-to-the-netherlands\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-sold-to-australia-and-to-the-netherlands\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-sold-to-australia-and-to-the-netherlands\/","name":"First XPS\u2122 sold to Australia and to the Netherlands - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2017-04-12T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-sold-to-australia-and-to-the-netherlands\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-sold-to-australia-and-to-the-netherlands\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-xps-sold-to-australia-and-to-the-netherlands\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"First XPS\u2122 sold to Australia and to the Netherlands"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}